Market open
LivaNova/$LIVN
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About LivaNova
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.
Ticker
$LIVN
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
2,900
Website
LivaNova Metrics
BasicAdvanced
$2.6B
112.41
$0.43
0.99
-
Price and volume
Market cap
$2.6B
Beta
0.99
52-week high
$64.48
52-week low
$43.15
Average daily volume
527K
Financial strength
Current ratio
3.37
Quick ratio
1.675
Long term debt to equity
49.496
Total debt to equity
51.176
Interest coverage (TTM)
2.79%
Management effectiveness
Return on assets (TTM)
3.77%
Return on equity (TTM)
1.87%
Valuation
Price to earnings (TTM)
112.405
Price to revenue (TTM)
2.103
Price to book
2
Price to tangible book (TTM)
9.36
Price to free cash flow (TTM)
24.041
Growth
Revenue change (TTM)
11.04%
Earnings per share change (TTM)
760.58%
3-year revenue growth (CAGR)
6.26%
3-year earnings per share growth (CAGR)
-62.89%
What the Analysts think about LivaNova
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for LivaNova stock.
LivaNova Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
LivaNova Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
LivaNova News
AllArticlesVideos
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results
Business Wire·6 days ago
LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting
Business Wire·2 months ago
LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for LivaNova stock?
LivaNova (LIVN) has a market cap of $2.6B as of January 27, 2025.
What is the P/E ratio for LivaNova stock?
The price to earnings (P/E) ratio for LivaNova (LIVN) stock is 112.41 as of January 27, 2025.
Does LivaNova stock pay dividends?
No, LivaNova (LIVN) stock does not pay dividends to its shareholders as of January 27, 2025.
When is the next LivaNova dividend payment date?
LivaNova (LIVN) stock does not pay dividends to its shareholders.
What is the beta indicator for LivaNova?
LivaNova (LIVN) has a beta rating of 0.99. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.